Kimberly Pugh
Endocrinology, Diabetes & Metabolism · Clinton, SCNPI 1912965831
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,910 of the $6,223 with a category attached, or 78.9%. It is spread thinly across 31 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,131 and has fallen 98.8% since, to $27 in 2025.
Across 244 payments — averaging $25.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$1K
- Lilly USA, LLC$863
- Novo Nordisk$844
- Insulet Corporation$470
- AstraZeneca$372
- Amgen$337
- plus $2K from 25 others
What the payments were for
- Consulting fees$2444%
- Speaking & faculty fees$87514%
- Food & beverage$4,91079%
- Education$1342%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 13 | $1,063 |
| Lilly USA, LLC | 32 | $863 |
| Novo Nordisk | 29 | $844 |
| Insulet Corporation | 16 | $470 |
| AstraZeneca(2 entities) | 18 | $372 |
| Amgen(2 entities) | 15 | $337 |
| Valeritas, Inc. | 12 | $269 |
| Abbott | 13 | $266 |
| Mannkind Corporation | 15 | $257 |
| Sanofi-aventis U.S. LLC | 15 | $255 |
| Dexcom, Inc. | 8 | $167 |
| AbbVie | 9 | $150 |
| Johnson & Johnson | 7 | $102 |
| Chiasma, Inc. | 1 | $97 |
| IBSA Pharma Inc. | 5 | $93 |
| Merck | 6 | $90 |
| Boehringer Ingelheim | 5 | $76 |
| Zealand Pharma US, Inc. | 4 | $75 |
| Radius Health, Inc. | 3 | $69 |
| Medtronic | 4 | $67 |
| Novartis | 3 | $47 |
| BD | 2 | $35 |
| Fisher & Paykel Healthcare Inc | 1 | $27 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Lifescan, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,223 in reported general payments places this provider in the 65th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.
See all endocrinology, diabetes & metabolism providers in South Carolina →
Other endocrinology, diabetes & metabolism in Clinton
- Gauri DhirMyrtle Beach$417K
- Cory WhiteGreenville$413K
- Louis HaenelCharleston$377K
- Vonda CalcuttWalterboro$368K
- Ray VaughtersAiken$321K
- Donald EagertonMyrtle Beach$284K
- Beatrice HullCharleston$214K
- Joseph MathewsSummerville$168K
- Brittany HendersonMount Pleasant$157K
- Zouhair BibiConway$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.